Liren Tang

Chief Executive Officer at Welichem Biotech, Inc.

Health Technology

Consumer Services

Commercial Services

Profile

Liren Tang is currently the President & Chief Executive Officer at Welichem Biotech, Inc. since 2009.
Previously, he worked as a Principal at Vancouver Coastal Health Research Institute.
Dr. Tang holds a doctorate degree from the University of British Columbia.

Liren Tang active positions

Companies	Position	Start
Welichem Biotech, Inc. Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada.	Chief Executive Officer	17/11/2009

All active positions of Liren Tang

Former positions of Liren Tang

Companies	Position	End
Vancouver Coastal Health Research Institute Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada.	Corporate Officer/Principal	-

See the detail of Liren Tang's experience

Training of Liren Tang

University of British Columbia

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Liren Tang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Welichem Biotech, Inc. Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada.	Health Technology
Vancouver Coastal Health Research Institute Vancouver Coastal Health Research Institute Miscellaneous Commercial ServicesCommercial Services Vancouver Coastal Health Research Institute operates as a health research institute. It offers orientation, clinical trials administration, intellectual property, and community research services. The company is headquartered in Vancouver, Canada.	Commercial Services